Literature DB >> 23290438

Biology of graft-versus-host responses: recent insights.

Kelli P MacDonald1, Warren D Shlomchik, Pavan Reddy.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23290438      PMCID： PMC3543773          DOI： 10.1016/j.bbmt.2012.11.005

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  50 in total

Review 1.  Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.

Authors:  Elizabeth O Stenger; Hēth R Turnquist; Markus Y Mapara; Angus W Thomson
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

2.  Regulation of acute graft-versus-host disease by microRNA-155.

Authors:  Parvathi Ranganathan; Catherine E A Heaphy; Stefan Costinean; Nicole Stauffer; Caroline Na; Mehdi Hamadani; Ramasamy Santhanam; Charlene Mao; Patricia A Taylor; Sukhinder Sandhu; Gang He; Arwa Shana'ah; Gerard J Nuovo; Alessandro Lagana; Luciano Cascione; Susanna Obad; Oliver Broom; Sakari Kauppinen; John C Byrd; Michael Caligiuri; Danilo Perrotti; Gregg A Hadley; Guido Marcucci; Steven M Devine; Bruce R Blazar; Carlo M Croce; Ramiro Garzon
Journal:  Blood       Date:  2012-03-09       Impact factor: 22.113

3.  Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells.

Authors:  Tomomi Toubai; Isao Tawara; Yaping Sun; Chen Liu; Evelyn Nieves; Rebecca Evers; Thea Friedman; Robert Korngold; Pavan Reddy
Journal:  Blood       Date:  2011-11-18       Impact factor: 22.113

4.  Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subsets.

Authors:  Kate A Markey; Motoko Koyama; Rachel D Kuns; Katie E Lineburg; Yana A Wilson; Stuart D Olver; Neil C Raffelt; Alistair L J Don; Antiopi Varelias; Renee J Robb; Melody Cheong; Christian R Engwerda; Raymond J Steptoe; Hayley S Ramshaw; Angel F Lopez; Javier Vega-Ramos; Andrew M Lew; Jose A Villadangos; Geoffrey R Hill; Kelli P A MacDonald
Journal:  Blood       Date:  2012-03-13       Impact factor: 22.113

5.  Recipient B cells are not required for graft-versus-host disease induction.

Authors:  Catherine Matte-Martone; Xiajian Wang; Britt Anderson; Dhanpat Jain; Anthony J Demetris; Jennifer McNiff; Mark J Shlomchik; Warren D Shlomchik
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-23       Impact factor: 5.742

Review 6.  Physiological and pathological roles for microRNAs in the immune system.

Authors:  Ryan M O'Connell; Dinesh S Rao; Aadel A Chaudhuri; David Baltimore
Journal:  Nat Rev Immunol       Date:  2010-02       Impact factor: 53.106

7.  Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma.

Authors:  Geoffrey R Hill; Stuart D Olver; Rachel D Kuns; Antiopi Varelias; Neil C Raffelt; Alistair L Don; Kate A Markey; Yana A Wilson; Mark J Smyth; Yoichiro Iwakura; Joel Tocker; Andrew D Clouston; Kelli P A Macdonald
Journal:  Blood       Date:  2010-04-30       Impact factor: 22.113

8.  An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation.

Authors:  Kelli P A MacDonald; James S Palmer; Stephen Cronau; Elke Seppanen; Stuart Olver; Neil C Raffelt; Rachel Kuns; Allison R Pettit; Andrew Clouston; Brandon Wainwright; Dan Branstetter; Jeffrey Smith; Raymond J Paxton; Douglas Pat Cerretti; Lynn Bonham; Geoffrey R Hill; David A Hume
Journal:  Blood       Date:  2010-08-03       Impact factor: 22.113

9.  PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice.

Authors:  Javier O Valenzuela; Cristina Iclozan; Mohammad S Hossain; Martin Prlic; Emily Hopewell; Crystina C Bronk; Junmei Wang; Esteban Celis; Robert W Engelman; Bruce R Blazar; Michael J Bevan; Edmund K Waller; Xue-Zhong Yu; Amer A Beg
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

10.  STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease.

Authors:  Arian Laurence; Shoba Amarnath; Jacopo Mariotti; Yong Chan Kim; Jason Foley; Michael Eckhaus; John J O'Shea; Daniel H Fowler
Journal:  Immunity       Date:  2012-08-24       Impact factor: 31.745
View more
  22 in total

Review 1.  Microbiome-intestine cross talk during acute graft-versus-host disease.

Authors:  Hind Rafei; Robert R Jenq
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

2.  Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response.

Authors:  Cornelis A M van Bergen; Simone A P van Luxemburg-Heijs; Liesbeth C de Wreede; Matthijs Eefting; Peter A von dem Borne; Peter van Balen; Mirjam H M Heemskerk; Arend Mulder; Fransiscus H J Claas; Marcelo A Navarrete; Wilhelmina M Honders; Caroline E Rutten; Hendrik Veelken; Inge Jedema; Constantijn J M Halkes; Marieke Griffioen; J H Frederik Falkenburg
Journal:  J Clin Invest       Date:  2017-01-09       Impact factor: 14.808

3.  Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.

Authors:  Martin Vaeth; Carina A Bäuerlein; Tobias Pusch; Janina Findeis; Martin Chopra; Anja Mottok; Andreas Rosenwald; Andreas Beilhack; Friederike Berberich-Siebelt
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

4.  T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice.

Authors:  Jianing Fu; Yongxia Wu; Hung Nguyen; Jessica Heinrichs; Steven Schutt; Yuejun Liu; Chen Liu; Junfei Jin; Claudio Anasetti; Xue-Zhong Yu
Journal:  J Immunol       Date:  2016-02-22       Impact factor: 5.422

5.  Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease.

Authors:  Govindarajan Thangavelu; Jing Du; Katelyn G Paz; Michael Loschi; Michael C Zaiken; Ryan Flynn; Patricia A Taylor; Andrew Kemal Kirchmeier; Angela Panoskaltsis-Mortari; Leo Luznik; Kelli P MacDonald; Geoffrey R Hill; Ivan Maillard; David H Munn; Jonathan S Serody; William J Murphy; David Miklos; Corey S Cutler; John Koreth; Joseph H Antin; Robert J Soiffer; Jerome Ritz; Carol Dahlberg; Andrew T Miller; Bruce R Blazar
Journal:  Blood       Date:  2020-01-02       Impact factor: 22.113

Review 6.  Role of the intestinal mucosa in acute gastrointestinal GVHD.

Authors:  Jonathan U Peled; Alan M Hanash; Robert R Jenq
Journal:  Blood       Date:  2016-11-17       Impact factor: 22.113

7.  Chemical and genetic control of IFNγ-induced MHCII expression.

Authors:  Ruud H Wijdeven; Marvin M van Luijn; Annet F Wierenga-Wolf; Jimmy J Akkermans; Peter J van den Elsen; Rogier Q Hintzen; Jacques Neefjes
Journal:  EMBO Rep       Date:  2018-07-18       Impact factor: 8.807

8.  OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation.

Authors:  Udo Holtick; Jens-Markus Chemnitz; Alexander Shimabukuro-Vornhagen; Sebastian Theurich; Geothy Chakupurakal; Anke Krause; Anne Fiedler; Leo Luznik; Martin Hellmich; Dominik Wolf; Michael Hallek; Michael von Bergwelt-Baildon; Christof Scheid
Journal:  Eur J Haematol       Date:  2015-03-16       Impact factor: 2.997

9.  SYK inhibitor entospletinib prevents ocular and skin GVHD in mice.

Authors:  Jonathan C Poe; Wei Jia; Julie A Di Paolo; Nancy J Reyes; Ji Yun Kim; Hsuan Su; John S Sundy; Adela R Cardones; Victor L Perez; Benny J Chen; Nelson J Chao; Diana M Cardona; Daniel R Saban; Stefanie Sarantopoulos
Journal:  JCI Insight       Date:  2018-10-04

Review 10.  Immune Modulation in Hematologic Malignancies.

Authors:  Madhav V Dhodapkar; Kavita M Dhodapkar
Journal:  Semin Oncol       Date:  2015-06-03       Impact factor: 4.929
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.